Published in J Int AIDS Soc on April 20, 2010
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol (2016) 1.71
Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol (2011) 1.29
HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia. AIDS Behav (2011) 1.12
Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology (2013) 1.09
Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav (2012) 1.08
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther (2014) 1.08
A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS One (2013) 0.97
The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol (2013) 0.96
Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review. BMC Public Health (2014) 0.91
Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana. PLoS One (2011) 0.89
Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders. J Neurovirol (2013) 0.86
The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates. PLoS One (2014) 0.84
HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project. HIV Med (2014) 0.82
Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda. J Neurovirol (2013) 0.82
Neurocognitive deficits in HIV-infected women and victims of childhood trauma. AIDS Care (2012) 0.82
HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. PLoS One (2014) 0.81
Neurology and the Global HIV Epidemic. Semin Neurol (2014) 0.81
Symptoms of common mental disorder and cognitive associations with seropositivity among a cohort of people coming for testing for HIV/AIDS in Goa, India: a cross-sectional survey. BMC Public Health (2013) 0.81
Prevalence of HIV-Associated Neurocognitive Disorder (HAND) among Patients Attending a Tertiary Health Facility in Northern Nigeria. J Int Assoc Provid AIDS Care (2014) 0.81
Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol (2013) 0.79
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic. PLoS One (2016) 0.75
Prevalence of HIV Associated Neurocognitive Deficit among HIV Positive People in Ethiopia: A Cross Sectional Study at Ayder Referral Hospital. Ethiop J Health Sci (2017) 0.75
Multivariable analysis to determine if HIV-1 Tat dicysteine motif is associated with neurodevelopmental delay in HIV-infected children in Malawi. Behav Brain Funct (2015) 0.75
Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia. AIDS Behav (2016) 0.75
Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist (1969) 45.63
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA (1994) 17.56
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr (2007) 4.30
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology (2007) 3.14
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis (2002) 2.54
Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis (1999) 2.32
WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry (1994) 2.25
Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol (2004) 2.22
Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol (2007) 2.03
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retroviruses (2008) 1.84
Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev (2009) 1.73
Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol (2007) 1.73
Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol (1993) 1.67
Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol (2008) 1.64
Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord (2007) 1.56
Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology (2006) 1.56
Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc (2007) 1.54
Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology (2008) 1.44
Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology (2006) 1.42
Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev (2002) 1.36
Depression and suicidality in HIV/AIDS in China. J Affect Disord (2006) 1.32
Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol (2007) 1.30
Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry (1994) 1.24
Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. AIDS Behav (2004) 1.11
Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. J Clin Exp Neuropsychol (2007) 1.10
Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J Neurovirol (2007) 1.01
Depression among HIV-positive individuals in Botswana: a behavioral surveillance. AIDS Behav (2011) 0.98
Subjective memory complaints, mood, and memory deficits among HIV/AIDS patients in Hong Kong. J Clin Exp Neuropsychol (2007) 0.82
Characteristics of homeless HIV-positive outreach responders in urban US and their success in primary care treatment. AIDS Care (2006) 0.82
Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia. Eur J Neurol (2000) 0.81